Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.

Journal of medical virology - 1 Dec 2010

Balode Dace, Westman Maj, Kolupajeva Tatjana, Rozentale Baiba, Albert Jan

Abstract excerpt

Transmitted drug resistance (TDR) is a concern because it may reduce the efficacy of antiretroviral treatment. Plasma samples of 119 HIV-1-infected patients who were newly diagnosed at the Infectology Center of Latvia in 2005 and 2006 were analyzed by an in-house genotypic resistance assay to determine the prevalence of TDR in Latvia. TDR was identified using the WHO 2009 list of mutations for surveillance of TDR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Latvia

Share to Microbial Sensitivity Tests

Share to Prevalence

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 20981787
DOI: 10.1002/jmv.21921

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.PMID 20981787Read ↗

HIV drug resistance tendencies in Latvia.Semantic proximity Read ↗

HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.Semantic proximity Read ↗

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010.Semantic proximity Read ↗

Primary drug resistance in South Africa: data from 10 years of surveys.Semantic proximity Read ↗

Short communication: High prevalence of transmitted antiretroviral drug resistance among newly HIV type 1 diagnosed adults in Mombasa, Kenya.Semantic proximity Read ↗

Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa.Semantic proximity Read ↗

Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.Semantic proximity Read ↗

High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.Semantic proximity Read ↗

Transmission and prevalence of HIV resistance among treatment-naive subjects.Semantic proximity Read ↗

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort.Semantic proximity Read ↗

Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study.Semantic proximity Read ↗

Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.